Leearne Hinch
Chief Executive Officer chez INOVIQ LTD
Profil
Leearne Maree Hinch currently works at INOVIQ Ltd., as Chief Executive Officer from 2016 and BARD1AG SA, as Director.
Dr. Hinch also formerly worked at Chemeq Ltd., as Chief Executive Officer, Immuron Ltd., as Chief Executive Officer in 2015, Holista CollTech Ltd., as Chief Executive Officer, Virbac (Australia) Pty Ltd., as Chief Executive Officer, Eustralis Pharmaceuticals Ltd., as Chief Executive Officer, CollTech Australia Ltd., as General Manager, and Wellfully Ltd., as Chief Operating Officer.
Dr. Hinch received her Masters Business Admin degree in 1920 from Curtin University and undergraduate degree from Murdoch University.
Postes actifs de Leearne Hinch
| Sociétés | Poste | Début |
|---|---|---|
| INOVIQ LTD | Chief Executive Officer | 07/11/2016 |
BARD1AG SA
 BARD1AG SA Medical/Nursing ServicesHealth Services BARD1AG SA develops blood tests for the early detection of colorectal and lung cancer based on cancer-specific BARD1 isoforms. It offers screening and diagnosis services. The company was founded by Irmgard Irminger-Finger and Tony Walker in 2010 is headquartered in Geneva, Switzerland. | Director/Board Member | - |
Anciens postes connus de Leearne Hinch
| Sociétés | Poste | Fin |
|---|---|---|
| IMMURON LIMITED | Chief Executive Officer | 08/07/2015 |
| WELLFULLY LIMITED | Chief Operating Officer | 06/02/2009 |
CollTech Australia Ltd.
 CollTech Australia Ltd. BiotechnologyHealth Technology The Company's principal activity is producing and selling of collagen and other biomaterials from animal sources in Australia. | Corporate Officer/Principal | - |
Virbac (Australia) Pty Ltd.
 Virbac (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac (Australia) Pty Ltd. is an Australian company that manufactures veterinary pharmaceuticals and vaccines. The private company is based in Milperra, Australia. | Chief Executive Officer | - |
Chemeq Ltd.
 Chemeq Ltd. BiotechnologyHealth Technology Chemeq Ltd. develops, manufactures and markets polymeric antimicrobials drugs for the control of disease causing bacteria in commercial animal production. It is focused on its CHEMEQ® polymeric antimicrobial for the prevention and control of intestinal bacterial diseases in feedstock animals such as pigs and poultry. The company was founded in 1985 and is headquartered in Rockingham, Australia. | Chief Executive Officer | - |
Formation de Leearne Hinch
| Curtin University | Masters Business Admin |
| Murdoch University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| WELLFULLY LIMITED | Health Technology |
| IMMURON LIMITED | Health Technology |
| HOLISTA COLLTECH LIMITED | Health Technology |
| INOVIQ LTD | Health Services |
| Entreprise privées | 5 |
|---|---|
Chemeq Ltd.
Chemeq Ltd. BiotechnologyHealth Technology Chemeq Ltd. develops, manufactures and markets polymeric antimicrobials drugs for the control of disease causing bacteria in commercial animal production. It is focused on its CHEMEQ® polymeric antimicrobial for the prevention and control of intestinal bacterial diseases in feedstock animals such as pigs and poultry. The company was founded in 1985 and is headquartered in Rockingham, Australia. | Health Technology |
CollTech Australia Ltd.
CollTech Australia Ltd. BiotechnologyHealth Technology The Company's principal activity is producing and selling of collagen and other biomaterials from animal sources in Australia. | Health Technology |
Virbac (Australia) Pty Ltd.
Virbac (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Virbac SA, Virbac (Australia) Pty Ltd. is an Australian company that manufactures veterinary pharmaceuticals and vaccines. The private company is based in Milperra, Australia. | Health Technology |
BARD1AG SA
BARD1AG SA Medical/Nursing ServicesHealth Services BARD1AG SA develops blood tests for the early detection of colorectal and lung cancer based on cancer-specific BARD1 isoforms. It offers screening and diagnosis services. The company was founded by Irmgard Irminger-Finger and Tony Walker in 2010 is headquartered in Geneva, Switzerland. | Health Services |
Eustralis Pharmaceuticals Ltd.
 Eustralis Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eustralis Pharmaceuticals Ltd. manufactures pharmaceutical products. The private company is based in Perth, Australia. | Health Technology |
